TG Therapeutics agrees to purchase a global license to a Car T cell therapy program for autoimmune diseases

TG Therapeutics Inc.’s stock rallied 11% early Wednesday, after the biotech said it’s entered an agreement with microcap Precision BioSciencies Inc. to...

Related Keywords

Azercabtagene Zapreleucel ,Tg Therapeutics Inc ,Precision Biosciencies Inc ,Precision Biosciencies ,Article Normal ,Biotechnology ,Acquisitions Mergers Takeovers ,Corporate Industrial News ,Tgtx ,Precision Biosciences Inc ,Dtil ,Acquisitions ,Mergers ,Takeovers ,Corporate ,Industrial News ,